Other
A US bipartisan group of senators has reached a deal on capping the price of insulin at USD 35, Semafor reports
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
